ProclaimRx Launches AI Platform for Pharmaceutical Commercial Intelligence
ProclaimRx has launched an enterprise-grade AI platform that converts complex pharmaceutical data into real-time, decision-ready insights, announced in a press release. The platform, powered by the PLAiTO Intelligence Engine, aims to replace manual analysis processes with automated intelligence to help commercial teams optimize investments, target customers, and analyze performance within minutes.
The company stated that the platform can automate brand and sales data analysis, reclaiming up to 15 hours per week, and supports investment decisions through on-demand simulations and modeling. It also provides access to proprietary benchmarks and insights while maintaining enterprise-level data security.
As part of the launch, ProclaimRx appointed Eugene Lee as Chief Commercial Officer and Kathy Contratto as Vice President of Customer Operations. Both bring extensive experience in healthcare and life sciences leadership roles. The company will showcase live demos and host an interactive panel at the Pharma CX Marketing Summit in Philadelphia on October 20–21, 2025.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Prologue Medicines names Stephen Harrison chief scientific officer
CPG Radar rolls out Signals and LeadLogic for product research and sales
PR Newswire Marks One Year of Amplify AI Platform
Veeva to Showcase Falcon and Vault AI at Boston Summit
AllyGPO Wins Silver Stevie Award for AllyIQ Platform
Daily AI Brief: the AI news that matters, in your inbox.